Compound ID | 2045
Class: Quinolone
Spectrum of activity: | Gram-negative |
Details of activity: | Binds to type II topoisomerases, gyrase and topoisomerase IV and thus, inhibits DNA cleavage and ligation reactions. It kills bacterial cells by increasing the concentration of enzyme–DNA cleavage complexes, thereby inhibiting cell replication. |
Description: | Synthetic pyridopyrimidine derivative, closely related to oxolinic acid and nalidixic acid |
Year first mentioned: | 1967 |
Development status: | Approved, withdrawn in most countries |
Chemical structure(s): | |
Canonical SMILES: | CCN1C=C(C(=O)C2=C1N=C(N=C2)N3CCCC3)C(=O)O |
Isomeric SMILES: | CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O |
InChI: | InChI=1S/C14H16N4O3/c1-2-17-8-10(13(20)21)11(19)9-7-15-14(16-12(9)17)18-5-3-4-6-18/h7-8H,2-6H2,1H3,(H,20,21) |
InChI Key: | RCIMBBZXSXFZBV-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/4855 |
External links: | |
Guide to Pharmacology: | piromidic acid |
Main Source: | https://academic.oup.com/jambio/article-abstract/44/2/191/6729064?redirectedFrom=fulltext |